Daxxify, developed by Revance Therapeutics, and FDA-approved in 2022, is designed to reduce the appearance of wrinkles by temporarily relaxing facial muscles. It offers longer-lasting results compared to traditional wrinkle relaxers, with effects potentially extending up to six months or more. Ideal for smoothing frown lines and other dynamic wrinkles, Daxxify helps patients achieve a rejuvenated, youthful appearance.